Insulet | PODD - Stammkapital

Aktienkurs
219.84
Täglich Wechseln
-16.23 -6.88%
Monatlich
-10.76%
Jährlich
-13.94%
Q1 Prognose
229.85




Stammkapital Veränderung Datum
Abbott USD 1.74B 23.39B 2025-09
Align Technology USD 71.75M 736K 2025-12
AtriCure USD 49.7M 10K 2025-09
Avanos Medical USD 46.46M 39.46K 2025-12
Baxter International USD 514.28M 168.72M 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Boston Scientific USD 1.48B 1.46B 2025-06
Cardinal Health USD 238M 1000K 2025-09
Cooper Companies USD 195.1M 3.71M 2025-12
Dexcom USD 384.8M 5.2M 2025-12
Edwards Lifesciences USD 580.7M 7.2M 2025-09
Eli Lilly USD 946.83M 354.23M 2025-06
Globus Medical USD 135.06M 449K 2025-12
ICU Medical USD 24.69M 2K 2025-12
Inogen USD 23K 0 2023-12
Insulet USD 70.35M 1000 2025-12
Integra LifeSciences USD 77.89M 34K 2025-12
J&J USD 2.41B 584K 2025-09
Masimo USD 52.1M 1000K 2025-12
Medtronic USD 1.28B 116K 2025-09
Merit Medical Systems USD 59.29M 72K 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Solventum Corp USD 173.49M 51.34K 2025-12
Stryker USD 382.4M 93K 2025-12
Tandem Diabetes Care USD 68.29M 518K 2025-12
Teleflex USD 44.19M 1000 2025-12
West Pharmaceutical Services USD 72M 100K 2025-12
Zimmer Biomet Holdings USD 198.18M 18.44K 2025-12